MANAGEMENT TEAM
CAROL ANN MIREIDER
Chief Executive Officer
30-yr industry veteran with extensive expertise in Go-To-Market-Strategy: Medical Devices, Pharma, Diagnostics, and Consumer
Served in Commercial leadership roles for BMS, J&J, Merck, Abbott, LabCorp, Estee Lauder
Expertise: Product Commercialization | Marketing Strategy Business Development | Operations | Organizational leadership Research & Metrics
University of Cambridge | UK | COH
Fairleigh Dickinson University | Bachelor of Science
Fashion Institute of Technology | AAS
GREGORY PETROFF
Consultant Partner, Reitler Kailas & Rosenblatt
Lead Securities Counsel since the company’s inception.
Tenured guiding clients throughout the corporate life cycle –startup to acquisition with deal values >$1.3 billion dollars.
Expertise: Mergers/acquisitions, PE, VC, Securities offerings, with reporting and disclosure.
Georgetown University Law Center (LL.M)
New England School of Law (J.D.)
Liberty University (B.S.)
STEVE LETTS
VP of Finance - Consultant
Commercial Advisor for PRPC where he develops financial models, formulates valuations and financial analysis.
Current serves as VP finance for Shell USA. Analyzes the economics for Shell’s multi billion-dollar low carbon fuels project portfolio. Global Responsible for financial operations: US, Canada, Argentina.
DR. ROBERT FRYKBERG
Chief Medical Officer – Consultant
Doctor of Podiatric Medicine (DPM) MPH, MAPWCA, FRSM, FFPM(Glasg), 21 years of private practice,
Harvard University – School of Public Health,
MPH – concentration in Quantitative Methods
Authored over 100 peer reviewed articles
Leading authority Wound Healing Market,
Ranked 9th Global Wound healing physician
ERIC ABRAMS
DPM, FACFAS, Chair, Optum Podiatry - Consultant
Doctor of Podiatric Medicine DPM, Private Practice
NJ provider of wound treatments using CASCADE® Clinical Instructor – Podiatric Surgical Residency, Jersey Shore Univ. Medical Center and staff at Jersey Shore University Medical Center.
Chair, Optum Podiatry Health Care System.
IRIS MARKLEIN
Consultant
MCRA Regulatory Affairs – Regenerative Medicine & Biologics Quality
9+ years in regulatory affairs, including 8 years at the FDA.
Expertise: clinical, reimbursement, and quality assurance. CBER lead for cell therapies and devices. CDRH Lead spinal and orthopedic devices.
Ph.D University of Pennsylvania Bioengineering with a focus on stem cells Bachelor of Science University of Texas, Biomedical Engineering.
CAROLYNYN
Consultant
MCRA Regulatory Affairs – Regenerative Medicine & Biologics Quality
25 years regenerative medicine- human cells/tissue-based products
11 years regulatory experience at the FDA. CBER designated subject matter expert in Advanced Manufacturing for drugs and biologics, focus on wound care products and implants.
Ph.D. from the Swiss Federal Institute of Technology, MS, Chemical Engineering
BS, Biomedical and Chemical Engineering, Johns Hopkins University.
AGNES MOLDOVAN
Consultant - Quality, Manufacturing Compliance
Regulatory, Quality and Compliance Leader with 20+ years GMP experience across multiple industries (in vitro diagnostics, medical device, pharma, OTC, BioPharma) Bristol Myers-Squibb, Sandos-Novartis, Abbott
Master of Science QA/RA
Temple Univ, PA, GPA: 4.0
Bachelor of Art (BA), Biomathematics
DAMON KEELEY
Founder
Founded PRP Concepts in 2014, 30-yr industry veteran in blood-based products
Previously the largest distributor of CASCADE® at Hemo Concepts, Inc.
